FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
Agios Pharma (NASDAQ: AGIO) reported Q3 EPS of ($1.63), $0.11 worse than the analyst estimate of ($1.52). Revenue for the quarter came in at $9 million versus the consensus estimate of $7.82 million.
For earnings history and earnings-related data on Agios Pharma (AGIO) click here.
... More
